Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Eaton KA, Fontaine C, Friedman DI, Conti N, Alteri CJ.

Vet Pathol. 2017 Jul;54(4):710-719. doi: 10.1177/0300985817691582. Epub 2017 Feb 8.

2.

Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models.

Golan L, Gonen E, Yagel S, Rosenshine I, Shpigel NY.

Dis Model Mech. 2011 Jan;4(1):86-94. doi: 10.1242/dmm.005777. Epub 2010 Oct 19.

3.

Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.

Eaton KA, Friedman DI, Francis GJ, Tyler JS, Young VB, Haeger J, Abu-Ali G, Whittam TS.

Infect Immun. 2008 Jul;76(7):3054-63. doi: 10.1128/IAI.01626-07. Epub 2008 Apr 28.

4.

Prophage induction, but not production of phage particles, is required for lethal disease in a microbiome-replete murine model of enterohemorrhagic E. coli infection.

Balasubramanian S, Osburne MS, BrinJones H, Tai AK, Leong JM.

PLoS Pathog. 2019 Jan 10;15(1):e1007494. doi: 10.1371/journal.ppat.1007494. eCollection 2019 Jan.

5.

Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin.

Zangari T, Melton-Celsa AR, Panda A, Smith MA, Tatarov I, De Tolla L, O'Brien AD.

Infect Immun. 2014 Dec;82(12):4968-77. doi: 10.1128/IAI.02361-14. Epub 2014 Sep 15.

6.
7.

The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.

Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S.

FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26.

8.

Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.

Bentancor LV, Mejías MP, Pinto A, Bilen MF, Meiss R, Rodriguez-Galán MC, Baez N, Pedrotti LP, Goldstein J, Ghiringhelli PD, Palermo MS.

MBio. 2013 Oct 1;4(5):e00501-13. doi: 10.1128/mBio.00501-13.

9.
10.

Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.

Mukherjee J, Chios K, Fishwild D, Hudson D, O'Donnell S, Rich SM, Donohue-Rolfe A, Tzipori S.

Infect Immun. 2002 Feb;70(2):612-9.

11.

Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.

Albanese A, Sacerdoti F, Seyahian EA, Amaral MM, Fiorentino G, Fernandez Brando R, Vilte DA, Mercado EC, Palermo MS, Cataldi A, Zotta E, Ibarra C.

Vaccine. 2018 Mar 20;36(13):1728-1735. doi: 10.1016/j.vaccine.2018.02.060. Epub 2018 Feb 23.

PMID:
29483033
12.

Inhibition of water absorption and selective damage to human colonic mucosa induced by Shiga toxin-2 are enhanced by Escherichia coli O157:H7 infection.

Albanese A, Gerhardt E, García H, Amigo N, Cataldi A, Zotta E, Ibarra C.

Int J Med Microbiol. 2015 May;305(3):348-54. doi: 10.1016/j.ijmm.2015.02.002. Epub 2015 Mar 5.

PMID:
25794836
13.

Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model.

Goswami K, Chen C, Xiaoli L, Eaton KA, Dudley EG.

Infect Immun. 2015 Nov;83(11):4185-93. doi: 10.1128/IAI.00663-15. Epub 2015 Aug 10.

14.

Salt at concentrations relevant to meat processing enhances Shiga toxin 2 production in Escherichia coli O157:H7.

Harris SM, Yue WF, Olsen SA, Hu J, Means WJ, McCormick RJ, Du M, Zhu MJ.

Int J Food Microbiol. 2012 Oct 15;159(3):186-92. doi: 10.1016/j.ijfoodmicro.2012.09.007. Epub 2012 Sep 19.

PMID:
23107496
15.

Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis.

Hall G, Kurosawa S, Stearns-Kurosawa DJ.

Infect Immun. 2018 Oct 25;86(11). pii: e00530-18. doi: 10.1128/IAI.00530-18. Print 2018 Nov.

16.

The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.

Shimizu T, Kawakami S, Sato T, Sasaki T, Higashide M, Hamabata T, Ohta T, Noda M.

Infect Immun. 2007 May;75(5):2189-200. Epub 2007 Feb 26.

18.

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA.

Int J Med Microbiol. 2013 Jan;303(1):1-8. doi: 10.1016/j.ijmm.2012.11.006. Epub 2013 Jan 10.

PMID:
23312798
19.

Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model.

Tyler JS, Beeri K, Reynolds JL, Alteri CJ, Skinner KG, Friedman JH, Eaton KA, Friedman DI.

PLoS Pathog. 2013 Mar;9(3):e1003236. doi: 10.1371/journal.ppat.1003236. Epub 2013 Mar 28.

20.

Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens.

Fuchs S, Mühldorfer I, Donohue-Rolfe A, Kerényi M, Emödy L, Alexiev R, Nenkov P, Hacker J.

Microb Pathog. 1999 Jul;27(1):13-23.

PMID:
10371706

Supplemental Content

Support Center